Healthcare News & Insights

How far can you trust your pharma-rep doc?

A new investigation shows that doctors drug companies hire as speakers and advisers aren’t always the best and the brightest in their fields. Some of them are outright criminals.

Senate report raises questions about FDA after-market review

A new report from the Senate Finance Committee highlights a potential conflict of interest within the FDA — and the safety of one of the world’s top-selling medications.

css.php